The Neuromuscular Disease Network for Canada


Craig Campbell


Head of the Division of Pediatric Neurology and Deputy Chair of the Department of Pediatrics

Associate Professor of Pediatrics, Epidemiology and Clinical Neurological Sciences, Western University

Email Craig

Read more about Craig


Dr Craig Campbell is the Deputy Chair of Pediatrics (Research), the Head of the Division of Pediatric Neurology and the medical director of the multidisciplinary neuromuscular clinic based at Thames Valley Children’s Centre and the Pediatric Neurophysiology Laboratory at Children’s Hospital London Health Sciences Centre. He is an Associate Professor in Pediatrics, Clinical Neurological Sciences and Epidemiology at Western University and a Scientist at the Children’s Health Research Institute. His training in pediatrics, neurology and epidemiology was completed at the University of Ottawa.

Dr. Campbell is collaboratively involved in many academic and industry initiated clinical trial activities in pediatric neuromuscular disease. He is a member of the Muscle Study Group and the World Muscle Society, and co-chair of the TREAT-NMD Registry Oversight Committee and Task Force. Dr Campbell has been awarded the George Karpati Award Researcher of the Year in 2011 and 2015 by Muscular Dystrophy Canada.

As part of NMD4C Dr Campbell is implementing innovations for the Canadian Neuromuscular Disease Registry that facilitate data sharing and patient engagement. He will also be developing a research curriculum and clinical trial network.

Recent publications

Campbell, C, Barohn, RJ, Bertini, E, Chabrol, B, Comi, GP, Darras, BT et al.. Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy. J Comp Eff Res. 2020.9 (14)973-984 PMID:32851872

Leclair, V, Landon-Cardinal, O, Aggarwal, R, Bansback, N, Campbell, C, Feldman, BM et al.. Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis. J Rheumatol. 2020.47 (10)1584-1586 PMID:32541080

Wagner, KR, Abdel-Hamid, HZ, Mah, JK, Campbell, C, Guglieri, M, Muntoni, F et al.. Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy. Neuromuscul Disord. 2020.30 (6)492-502 PMID:32522498

Hodgkinson, VL, Oskoui, M, Lounsberry, J, M'Dahoma, S, Butler, E, Campbell, C et al.. A National Spinal Muscular Atrophy Registry for Real-World Evidence. Can J Neurol Sci. 2020. 1-6 PMID:32493524

Wojtowicz, S, Lee, S, Chan, E, Ng, E, Campbell, CI, Di Guglielmo, GM et al.. SMURF2 and SMAD7 induce SARA degradation via the proteasome. Cell Signal. 2020.72 109627 PMID:32283253

See more on PubMed